Literature DB >> 25923127

A tale of two approaches: how metagenomics and proteomics are shaping the future of encephalitis diagnostics.

Ryan D Schubert1, Michael R Wilson.   

Abstract

PURPOSE OF REVIEW: We highlight how metagenomics and proteomics-based approaches are being applied to the problem of diagnosis in idiopathic encephalitis. RECENT
FINDINGS: Low cost, high-throughput next-generation sequencing platforms have enabled unbiased sequencing of biological samples. Rapid sequence-based computational algorithms then determine the source of all the nonhost (e.g., pathogen-derived) nucleic acids in a sample. This approach recently identified a case of neuroleptospirosis, resulting in a patient's dramatic clinical improvement with intravenous penicillin. Metagenomics also enabled the discovery of a neuroinvasive astrovirus in several patients. With regard to autoimmune encephalitis, advances in high throughput and efficient phage display of human peptides resulted in the discovery of autoantibodies against tripartite motif family members in a patient with paraneoplastic encephalitis. A complementary assay using ribosomes to display full-length human proteins identified additional autoantibody targets.
SUMMARY: Metagenomics and proteomics represent promising avenues of research to improve upon the diagnostic yield of current assays for infectious and autoimmune encephalitis, respectively.

Entities:  

Mesh:

Year:  2015        PMID: 25923127      PMCID: PMC4418212          DOI: 10.1097/WCO.0000000000000198

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  23 in total

1.  The perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columns.

Authors:  Samia N Naccache; Alexander L Greninger; Deanna Lee; Lark L Coffey; Tung Phan; Annie Rein-Weston; Andrew Aronsohn; John Hackett; Eric L Delwart; Charles Y Chiu
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project.

Authors:  Mary S Gable; Heather Sheriff; Josep Dalmau; Drake H Tilley; Carol A Glaser
Journal:  Clin Infect Dis       Date:  2012-01-26       Impact factor: 9.079

3.  Burden of encephalitis-associated hospitalizations in the United States, 1998-2010.

Authors:  Neil M Vora; Robert C Holman; Jason M Mehal; Claudia A Steiner; Jesse Blanton; James Sejvar
Journal:  Neurology       Date:  2014-01-02       Impact factor: 9.910

4.  Actionable diagnosis of neuroleptospirosis by next-generation sequencing.

Authors:  Michael R Wilson; Samia N Naccache; Erik Samayoa; Mark Biagtan; Hiba Bashir; Guixia Yu; Shahriar M Salamat; Sneha Somasekar; Scot Federman; Steve Miller; Robert Sokolic; Elizabeth Garabedian; Fabio Candotti; Rebecca H Buckley; Kurt D Reed; Teresa L Meyer; Christine M Seroogy; Renee Galloway; Sheryl L Henderson; James E Gern; Joseph L DeRisi; Charles Y Chiu
Journal:  N Engl J Med       Date:  2014-06-04       Impact factor: 91.245

5.  Protein interaction discovery using parallel analysis of translated ORFs (PLATO).

Authors:  Jian Zhu; H Benjamin Larman; Geng Gao; Romel Somwar; Zijuan Zhang; Uri Laserson; Alberto Ciccia; Natalya Pavlova; George Church; Wei Zhang; Santosh Kesari; Stephen J Elledge
Journal:  Nat Biotechnol       Date:  2013-03-17       Impact factor: 54.908

6.  Identification, characterization, and in vitro culture of highly divergent arenaviruses from boa constrictors and annulated tree boas: candidate etiological agents for snake inclusion body disease.

Authors:  Mark D Stenglein; Chris Sanders; Amy L Kistler; J Graham Ruby; Jessica Y Franco; Drury R Reavill; Freeland Dunker; Joseph L Derisi
Journal:  mBio       Date:  2012-08-14       Impact factor: 7.867

7.  Deep sequencing to identify the causes of viral encephalitis.

Authors:  Benjamin K Chan; Theodore Wilson; Kael F Fischer; John D Kriesel
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

8.  Use of staged molecular analysis to determine causes of unexplained central nervous system infections.

Authors:  Chien-Chin Hsu; Rafal Tokarz; Thomas Briese; Hung-Chin Tsai; Phenix-Lan Quan; W Ian Lipkin
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

9.  Comparison of three next-generation sequencing platforms for metagenomic sequencing and identification of pathogens in blood.

Authors:  Kenneth G Frey; Jesus Enrique Herrera-Galeano; Cassie L Redden; Truong V Luu; Stephanie L Servetas; Alfred J Mateczun; Vishwesh P Mokashi; Kimberly A Bishop-Lilly
Journal:  BMC Genomics       Date:  2014-02-04       Impact factor: 3.969

10.  A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples.

Authors:  Samia N Naccache; Scot Federman; Narayanan Veeraraghavan; Matei Zaharia; Deanna Lee; Erik Samayoa; Jerome Bouquet; Alexander L Greninger; Ka-Cheung Luk; Barryett Enge; Debra A Wadford; Sharon L Messenger; Gillian L Genrich; Kristen Pellegrino; Gilda Grard; Eric Leroy; Bradley S Schneider; Joseph N Fair; Miguel A Martínez; Pavel Isa; John A Crump; Joseph L DeRisi; Taylor Sittler; John Hackett; Steve Miller; Charles Y Chiu
Journal:  Genome Res       Date:  2014-06-04       Impact factor: 9.043

View more
  15 in total

1.  Prospective Cohort Study of Next-Generation Sequencing as a Diagnostic Modality for Unexplained Encephalitis in Children.

Authors:  Julia C Haston; Christina A Rostad; Robert C Jerris; Sarah S Milla; Courtney McCracken; Catherine Pratt; Michael Wiley; Karla Prieto; Gustavo Palacios; Andi L Shane; Anita K McElroy
Journal:  J Pediatric Infect Dis Soc       Date:  2020-07-13       Impact factor: 3.164

2.  Precision Metagenomics: Rapid Metagenomic Analyses for Infectious Disease Diagnostics and Public Health Surveillance.

Authors:  Ebrahim Afshinnekoo; Chou Chou; Noah Alexander; Sofia Ahsanuddin; Audrey N Schuetz; Christopher E Mason
Journal:  J Biomol Tech       Date:  2017-03-21

Review 3.  Nonsuppurative (Aseptic) Meningoencephalomyelitis Associated with Neurovirulent Astrovirus Infections in Humans and Animals.

Authors:  Gábor Reuter; Péter Pankovics; Ákos Boros
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

Review 4.  Autoimmune Epilepsy.

Authors:  Khalil S Husari; Divyanshu Dubey
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

5.  Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer.

Authors:  George J Xu; Ami A Shah; Mamie Z Li; Qikai Xu; Antony Rosen; Livia Casciola-Rosen; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

Review 6.  Diagnostic Testing of Neurologic Infections.

Authors:  Prashanth S Ramachandran; Michael R Wilson
Journal:  Neurol Clin       Date:  2018-11       Impact factor: 3.806

Review 7.  CNS Vasculitis: an Approach to Differential Diagnosis and Management.

Authors:  Kevin Byram; Rula A Hajj-Ali; Leonard Calabrese
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.686

8.  Clinical metagenomic identification of Balamuthia mandrillaris encephalitis and assembly of the draft genome: the continuing case for reference genome sequencing.

Authors:  Alexander L Greninger; Kevin Messacar; Thelma Dunnebacke; Samia N Naccache; Scot Federman; Jerome Bouquet; David Mirsky; Yosuke Nomura; Shigeo Yagi; Carol Glaser; Michael Vollmer; Craig A Press; Bette K Kleinschmidt-DeMasters; Bette K Klenschmidt-DeMasters; Samuel R Dominguez; Charles Y Chiu
Journal:  Genome Med       Date:  2015-12-01       Impact factor: 11.117

Review 9.  The Clinical Approach to Encephalitis.

Authors:  Amanda L Piquet; Tracey A Cho
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 6.030

10.  Chronic Meningitis: Simplifying a Diagnostic Challenge.

Authors:  Kelly Baldwin; Chris Whiting
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 6.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.